
### [NCIT:C91248](http://purl.obolibrary.org/obo/NCIT_C91248)
**Label:** Oropharyngeal Carcinoma by AJCC v7 Stage

**Subclasses:** [NCIT:C6039](http://purl.obolibrary.org/obo/NCIT_C6039) (Stage 0 Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7), [NCIT:C8218](http://purl.obolibrary.org/obo/NCIT_C8218) (Stage II Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7), [NCIT:C8219](http://purl.obolibrary.org/obo/NCIT_C8219) (Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7), [NCIT:C8217](http://purl.obolibrary.org/obo/NCIT_C8217) (Stage I Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7), [NCIT:C8049](http://purl.obolibrary.org/obo/NCIT_C8049) (Stage II Oropharyngeal Carcinoma AJCC v6 and v7), [NCIT:C115089](http://purl.obolibrary.org/obo/NCIT_C115089) (Stage IV Oropharyngeal Undifferentiated Carcinoma AJCC v7), [NCIT:C8048](http://purl.obolibrary.org/obo/NCIT_C8048) (Stage I Oropharyngeal Carcinoma AJCC v6 and v7), [NCIT:C115088](http://purl.obolibrary.org/obo/NCIT_C115088) (Stage III Oropharyngeal Undifferentiated Carcinoma AJCC v7), [NCIT:C115087](http://purl.obolibrary.org/obo/NCIT_C115087) (Stage II Oropharyngeal Undifferentiated Carcinoma AJCC v6 and v7), [NCIT:C115086](http://purl.obolibrary.org/obo/NCIT_C115086) (Stage I Oropharyngeal Undifferentiated Carcinoma AJCC v6 and v7), [NCIT:C4590](http://purl.obolibrary.org/obo/NCIT_C4590) (Stage 0 Oropharyngeal Carcinoma AJCC v6 and v7), [NCIT:C8220](http://purl.obolibrary.org/obo/NCIT_C8220) (Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7), [NCIT:C89023](http://purl.obolibrary.org/obo/NCIT_C89023) (Stage IV Oropharyngeal Carcinoma AJCC v7), [NCIT:C89021](http://purl.obolibrary.org/obo/NCIT_C89021) (Stage III Oropharyngeal Carcinoma AJCC v7), 

**Class expressions from DL-Learner:**

- Thing 53.20%
- [NCIT:C90530](http://purl.obolibrary.org/obo/NCIT_C90530) (AJCC v7 Stage) 53.12%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) 38.48%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39680](http://purl.obolibrary.org/obo/NCIT_C39680) (Doughnut Cell))) 38.48%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39679](http://purl.obolibrary.org/obo/NCIT_C39679) (Hallmark Cell))) 38.48%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39674](http://purl.obolibrary.org/obo/NCIT_C39674) (Anaplastic Large Cell Lymphoma, Giant Cell Rich Subtype))) 38.48%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39657](http://purl.obolibrary.org/obo/NCIT_C39657) (Neoplastic T-Lymphocyte with Clear Cytoplasm))) 38.48%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39652](http://purl.obolibrary.org/obo/NCIT_C39652) (Proliferation of Follicular Dendritic Cells Present))) 38.48%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39651](http://purl.obolibrary.org/obo/NCIT_C39651) (Proliferation of High Endothelial Venules Present))) 38.48%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39646](http://purl.obolibrary.org/obo/NCIT_C39646) (Erythroderma))) 38.48%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39640](http://purl.obolibrary.org/obo/NCIT_C39640) (Mucinous Degeneration))) 38.48%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39629](http://purl.obolibrary.org/obo/NCIT_C39629) (CDKN2A Gene Inactivation))) 38.48%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39628](http://purl.obolibrary.org/obo/NCIT_C39628) (Single Cell Exocytosis))) 38.48%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39627](http://purl.obolibrary.org/obo/NCIT_C39627) (Pautrier Microabscess Present))) 38.48%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39626](http://purl.obolibrary.org/obo/NCIT_C39626) (Epidermotropic Lymphocytic Infiltrate))) 38.48%


